Market Exclusive

Analyst Activity – Wedbush Reiterates Outperform on Miragen Therapeutics (NASDAQ:MGEN) (NASDAQ:MGEN)

Analyst Ratings For Miragen Therapeutics (NASDAQ:MGEN) (NASDAQ:MGEN)

Today, Wedbush reiterated its Outperform rating on Miragen Therapeutics (NASDAQ:MGEN) (NASDAQ:MGEN) with a price target of $19.00.

Some recent analyst ratings include

Recent Insider Trading Activity For Miragen Therapeutics (NASDAQ:MGEN) (NASDAQ:MGEN)
Miragen Therapeutics (NASDAQ:MGEN) (NASDAQ:MGEN) has insider ownership of 44.40% and institutional ownership of 18.98%.

Recent Trading Activity for Miragen Therapeutics (NASDAQ:MGEN) (NASDAQ:MGEN)
Shares of Miragen Therapeutics (NASDAQ:MGEN) closed the previous trading session at 6.89 down -0.13 1.85% with shares trading hands.

Exit mobile version